John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Emerson Electric
EMR
$87.7B
| $42.1M | 0.2% |
879,569
-1,043,505
| -54% | -$49.7M |
|
127
Global Payments
GPN
$24.7B
| $41.8M | 0.2% |
647,571
+328,499
| +103% | +$22.2M |
|
128
J.M. Smucker
SJM
$13.3B
| $41.2M | 0.2% |
334,375
+73,158
| +28% | +$8.72M |
|
129
Zoetis
ZTS
$32.1B
| $40.8M | 0.2% |
850,795
-801,145
| -48% | -$36.2M |
|
130
Manulife Financial
MFC
$70.5B
| $40.8M | 0.2% |
2,717,801
-954,638
| -26% | -$15.4M |
|
131
Crown Castle
CCI
$32.1B
| $40.4M | 0.19% |
467,584
-886,831
| -65% | -$75.3M |
|
132
GSK
GSK
$105B
| $40.4M | 0.19% |
800,475
-298,560
| -27% | -$15.2M |
|
133
Canadian Imperial Bank of Commerce
CM
$106B
| $40.3M | 0.19% |
1,223,126
+604,626
| +98% | +$22.2M |
|
134
Regions Financial
RF
$25.9B
| $40.1M | 0.19% |
4,179,415
+2,039,385
| +95% | +$19.6M |
|
135
Allegion
ALLE
$13.8B
| $39.9M | 0.19% |
604,638
+351,024
| +138% | +$22.5M |
|
136
Sherwin-Williams
SHW
$84.1B
| $39.7M | 0.19% |
458,661
-704,916
| -61% | -$61M |
|
137
Ameriprise Financial
AMP
$49.1B
| $38.9M | 0.19% |
365,590
-239,459
| -40% | -$26.8M |
|
138
Ryder
R
$9.58B
| $38.6M | 0.19% |
680,000
+537,050
| +376% | +$35.5M |
|
139
Bunge Global
BG
$21.7B
| $38.6M | 0.19% |
+565,342
| New | +$39.8M |
|
140
Jazz Pharmaceuticals
JAZZ
$16.5B
| $38.2M | 0.18% |
271,851
+212,263
| +356% | +$29.4M |
|
141
Teva Pharmaceuticals
TEVA
$43.5B
| $38.1M | 0.18% |
580,183
-1,164,814
| -67% | -$72M |
|
142
First Solar
FSLR
$23B
| $38.1M | 0.18% |
576,873
-36,442
| -6% | -$2.04M |
|
|
HOUS
143
DELISTED
Anywhere Real Estate
HOUS
| $37.2M | 0.18% |
1,014,899
+837,499
| +472% | +$33.1M |
|
144
Netflix
NFLX
$331B
| $37.1M | 0.18% |
3,240,240
-7,622,420
| -70% | -$87.1M |
|
145
Flex
FLEX
$40.8B
| $37M | 0.18% |
4,375,493
+3,749,056
| +598% | +$31.7M |
|
|
OPLN
146
Openlane
OPLN
$4.08B
| $36.7M | 0.18% |
2,617,559
+576,574
| +28% | +$8.16M |
|
|
FNFG
147
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $36.6M | 0.18% |
+3,377,438
| New | +$36M |
|
148
Vodafone
VOD
$36.9B
| $36.5M | 0.17% |
1,130,027
+1,006,102
| +812% | +$32.9M |
|
149
Check Point Software Technologies
CHKP
$13.3B
| $36.3M | 0.17% |
445,605
-525,150
| -54% | -$43.5M |
|
150
CALL
GE Aerospace
GE
$361B
| $35.9M | 0.17% |
240,170
+226,190
| +1,618% | +$32.1M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.